Rabovil 20mg Capsule
By Rabovil
Rx
10 Capsule in a Strip

Composition
Rabeprazole(20mg)

Manufacturer - Fibovil Pharmaceuticals Pvt Ltd
Plot No. 398, Industrial Area, Phase-1, Panchkula 134113

Expires on or after
September, 2025

liver
Rabovil 20mg Capsule is considered safe for use in patients with liver disease. It is important to note that no dose adjustment of Rabovil 20mg Capsule is necessary specifically for individuals with liver conditions. This means that individuals with liver issues can generally use this medication without requiring any changes in the prescribed dosage. It is advisable to follow the recommended dosage as provided by your healthcare provider. If you have any concerns or questions regarding the use of Rabovil 20mg Capsule in relation to liver health, it is recommended to consult with your doctor for personalized guidance and advice tailored to your specific medical condition.

kidney
Rabovil 20mg Capsule is safe for patients with kidney disease without requiring any dose adjustments.

alcohol
Caution is advised when drinking alcohol with Rabovil 20mg Capsule. Always consult your doctor before consuming alcohol with this medication.

driving
Rabovil 20mg Capsule may cause drowsiness, dizziness, and vision problems. It is advisable not to drive if experiencing these side effects.

pregnancy
Rabovil 20mg Capsule may not be safe to use during pregnancy as animal studies have shown harmful effects on the developing baby. Your doctor will consider the benefits and risks before prescribing it to you. Please consult your doctor before using Rabovil 20mg Capsule during pregnancy.

breastfeeding
Caution is advised when using Rabovil 20mg Capsule during breastfeeding. Limited data suggests it may pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | Sulfinylbenzimidazole Derivative |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | Proton pump inhibitors |
₹57
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024